4 completed, 1 withdrawn. 5 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 5 | Completed 4, Withdrawn 1 |
Follow DPP-4 inhibitor: new trials by email Literature Review of DPP-4 inhibitor trials Research Report on DPP-4 inhibitor
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Approaches To Therapy Escalation In T2D DPP-4 inhibitor, SGLT2 inhibitor, SGLT2 inhibitor and DPP-4 inhibitor - Type2 Diabetes | Phase 4 | Withdrawn | LMC Diabetes & Endocrinology Ltd. | 2019-05-01 | 2019-09-27 | |
| The Effects of Neprilysin on Glucagon-like Peptide-1 Entresto, Sitagliptin 100mg, Placebos - Diabetes, Heart Failure | Phase 4 | Completed | Nicolai Jacob Wewer Albrechtsen | 19 | 2018-05-17 | 2019-07-08 |
| Comparing the Renal Effect of Dipeptidyl-peptidase 4 Inhibitors and Sulfonylureas Dipeptidyl Peptidase 4 Inhibitor, Sulfonylurea - Type 2 Diabetes Mellitus, Proteinuria | Phase 4 | Completed | Changhua Christian Hospital | 101 | 2016-03-01 | 2019-06-14 |
| Efficacy and Safety of Insulin Glargine in Patients With Type 2 Diabetes With Inadequate Control on DPP-4 Inhibitor Therapy INSULIN GLARGINE, Metformin, DPP-4 inhibitor - Diabetes Mellitus, Type 2 | Phase 4 | Completed | Sanofi | 109 | 2013-12-01 | 2015-08-27 |
| Sitagliptin (DPP-4 Inhibitor) and NPH Insulin in Patients With T2D sitagliptin, NPH insulin - Type 2 Diabetes Mellitus | Phase 4 | Completed | University of Sao Paulo General Hospital | 40 | 2010-01-01 | 2015-11-18 |
Diabetes Mellitus, Type 2 (3) · Diabetes Mellitus (2) · Heart Failure (1) · Proteinuria (1)
Changhua Christian Hospital (1) · LMC Diabetes & Endocrinology Ltd. (1) · Nicolai Jacob Wewer Albrechtsen (1) · Sanofi (1) · University of Sao Paulo General Hospital (1)
Brazil (1) · Denmark (1) · South Korea (1)
Maria ER Siva, MD, PhD (1) · Ronald M. Goldenberg, MD (1) · Shih Te Tu, MD (1)